What is SLU-PP-332 commonly studied for
Providers increasingly encounter patients Read More Protecting Muscle While Treating Obesity: New Protein Targets for Older Adults on GLP-1s Jun 16, 2026 Articles, Diet and Nutrition, Exercise, Geriatric Medicine, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity 1,609 views The rise of highly effective GLP-1 receptor agonists and dual incretin therapies has transformed obesity treatment
Snack on Seeds and Nuts: Seeds and nuts are full of healthy fats, protein, and fiber
Dosing considerations for tirzepatide The tirzepatide dosing schedule typically starts at 2.5 mg weekly and can increase to 15 mg weekly
Research has demonstrated superior weight reduction outcomes compared to dual-agonist peptides, with subjects showing significant reductions in body fat, improved insulin sensitivity, and favourable changes in lipid profiles